While we see an increase in IFN-γ at earlier timepoints after treatment, which would be consistent with the increase in CD8+ T cells seen in the TME, the immune response is likely suppressed by the increase in PD-L1 expression on the tumor cells. The gene discussed is CD8A; the disease is neoplasm.